ABOUT THIS EPISODE
A Conversation with Gorana Capkun
Why You Should Listen
- Understand integrated evidence planning and how it connects evidence generation across functions, stakeholders, and geographies.
- Look beyond regulatory approval to consider what payers, physicians, and patients need from the evidence.
- Strengthen your contribution as a statistician by asking questions that clarify endpoints, study designs, and intended conclusions.
- Learn why patient perspectives matter when assessing treatment benefits and the practical challenges of clinical care.
- Recognise common planning mistakes that can delay access and reduce the impact of otherwise strong research.
Episode Highlights With Timestamp
- 02:23 — From pure mathematics to patient-focused evidence Gorana shares how her career across statistics, epidemiology, and pharmaceutical functions shaped her approach to evidence generation.
- 04:29 — What makes an evidence plan integrated? We discuss a shared strategic roadmap that connects different methods and stakeholder needs throughout the product life cycle.
- 07:17 — Why evidence planning should start in research Gorana explains how early collaboration helps teams understand unmet needs, disease burden, and how to measure success.
- 15:56 — Balancing expert advice with real-world data We explore how advisory boards can guide research—and why their observations may not tell the whole story.
- 18:49 — Aligning evidence needs before launch We discuss why early input from market access, medical affairs, and other functions matters when choosing endpoints and study designs.
- 25:59 — What changes after a treatment reaches patients? We examine how clinical practice reveals new questions about tolerability, treatment burden, and outcomes beyond trial populations.
- 29:44 — Common mistakes and how to avoid them Gorana shares why starting too late, working in silos, and unclear communication can undermine integrated evidence planning.
Links and Resources
- Merck Healthcare
- The Effective Statistician
- The Effective Statistician Academy — Explore the Academy and its learning resources. The Effective Statistician
- Join PSI — Learn about membership in the statistical community supporting healthcare research. psiweb.org
- Further reading: Integrated Evidence Planning for Enhancing Patient Care — Harnessing the Power of Real-World Evidence — A related publication co-authored by Gorana Capkun. PMC
English
United States
TRANSCRIPT 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
SEARCH PAST EPISODES
Search past episodes of The Effective Statistician - in association with PSI.
OTHER EPISODES IN THIS PODCAST
A Discussion with Andrew (Andy) York
**Episode Summary
**
What does “quality” really mean in statistical programming?
In this episode of The Effective Statistician, I speak with Andrew (Andy) York about the evolving world of programming validation, traceability, and quality assurance in clinical t…
A Conversation with Alun Bedding
Why You Should Listen
You want to build stronger, trust-based relationships at work
You’re leading teams and want measurable ways to improve culture
You want to understand how trust impacts retention and performance
You’re tired of “soft” leadership topics wit…
A Conversation with Anna Mosikian
Episode Overview
In this episode, I speak with Anna Mosikian, a physician by training and Global Clinical Program Lead working at the intersection of clinical development and strategic marketing.
Anna brings a powerful perspective on how clinical data translates …
A Conversation with Alun Bedding and Richard Zink
In this episode, I hand over the mic to Alun Bedding, who speaks with Richard Zink about a topic that might surprise many statisticians: applied improvisation.
At first glance, improv may seem unrelated to statistics or leadership. But as Richard s…
A Discussion with Alun Bedding and David Wright, Jürgen Hummel, and Jenny Devenport
This episode features three leading statistical methodology experts discussing the role, impact, and future of methodology groups in the pharmaceutical industry. They explore organizational structures, skill sets, A…
Disclaimer: The podcast and artwork embedded on this page are from Alexander Schacht and Benjamin Piske, biometricians, statisticians and leaders in the pharma industry, which is the property of its owner and not affiliated with or endorsed by Listen Notes, Inc.
EDIT
Thank you for helping to keep the podcast database up to date.